Singapore is committed to becoming Asia’s premier pharmaceutical and biomedical services centre. Millions of dollars have been invested, and a SGD500 million high tech biomedical park — Biopolis — has been developed in pursuit of this goal.
Our Singapore Pharmaceutical & Healthcare team is an integral part of a global industry group that spans 40 jurisdictions around the world. Our sector experience means that we understand the particular drivers relevant to the pharmaceutical industry, whether they be the transfer of marketing and manufacturing approvals or antitrust issues relating to the assignment of intellectual property rights following a merger, registrations with the Health Services Authority (HSA) of Singapore or how to maximize the incentives for foreign investment granted by the Economic Development Board when establishing a pharmaceutical operation in Singapore.
Learn more about how we can help .